Blog
RSS FeedPosted by Michael Wonder on 04 Nov 2020
PASC to consider comprehensive genomic profiling of non-small cell lung cancer tumour tissue specimens using next generation sequencing assays
4 November 2020 - First consideration of next generation sequencing. ...
Posted by Michael Wonder on 12 Nov 2019
Lung cancer ALK+NSCLC genetic mutation screening could save lives - doctors
12 November 2019 - Lives are being needlessly cut short because there's no universal testing for a type of lung ...
Posted by Michael Wonder on 28 Sep 2018
FDA authorizes first next generation sequencing-based test to detect very low levels of remaining cancer cells in patients with acute lymphoblastic leukaemia or multiple myeloma
28 September 2018 - Today the U.S. FDA permitted marketing of ClonoSEQ assay, a next generation sequencing-based test for minimal residual ...
Posted by Michael Wonder on 19 Nov 2017
What if you knew Alzheimer’s was coming for you?
17 November 2017 - Simple blood tests may soon be able to deliver alarming news about your cognitive health. ...
Posted by Michael Wonder on 15 Nov 2017
FDA unveils a streamlined path for the authorisation of tumour profiling tests alongside its latest product action
15 November 2017 - The U.S. FDA today authorised Memorial Sloan Kettering Cancer Center’s IMPACT (Integrated Mutation Profiling of Actionable Cancer ...